" /> Lanadelumab - CISMeF





Preferred Label : Lanadelumab;

NCIt synonyms : Lanadelumab-flyo;

NCIt definition : A fully human immunoglobulin G1 (IgG1) monoclonal antibody against plasma kallikrein that can be used for the treatment of hereditary angioedema (HAE). Upon administration, lanadelumab targets and binds to plasma kallikrein, thereby inhibiting its proteolytic activity. This inhibits the cleavage of high-molecular-weight-kininogen (HMWK) into cleaved HMWK (cHMWK) and bradykinin. This in turn may prevent bradykinin-driven vasodilation, the resulting increase in vascular permeability, and the swelling and pain associated with HAE. This may also prevent or improve pulmonary edema not associated with HAE and improve the associated decrease in blood oxygen levels.;

UNII : 2372V1TKXK;

CAS number : 1426055-14-2; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 1426055-14-2 alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo G-SRS /a ;

Drug name : Takhzyro;

Molecule name : SHP643; DX-2930; TAK-743;

NCI Metathesaurus CUI : CL971536;

Details


You can consult :


Nous contacter.
21/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.